Primary content

Related to 'Hepatocellular carcinoma'

People suspected of or diagnosed with pancreatic cancer, primary liver cancer, and cholangiocarcinoma in NSW should be referred to one of these specialist centres

People suspected of or diagnosed with pancreatic cancer, primary liver cancer, and cholangiocarcinoma in NSW should be referred to one of these specialist centres

Late hepatitis notifications have significantly declined in New South Wales since early 2000s; however, efforts to enhance hepatitis screening, particularly for HBV, are required.

All-cause survival following hepatitis B virus-hepatocellular carcinoma (HBV-HCC) has improved considerably, suggesting an impact of more effective antiviral therapy and earlier HCC diagnosis; in contrast, all-cause survival for hepatitis C virus-HCC is unchanged.